β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.
暂无分享,去创建一个
E. Tanaka | T. Wajima | N. Noguchi | S. Yamada | S. Seyama | Yuna Yuzawa | Masumi Saito
[1] E. Tanaka,et al. Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment. , 2019, Journal of global antimicrobial resistance.
[2] Y. Adachi,et al. Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan , 2018, Journal of medical microbiology.
[3] H. Sakata,et al. Invasive Haemophilus influenzae infections in children in Kamikawa subprefecture, Hokkaido, Japan, 2006-2015: The effectiveness of H. influenzae type b vaccine. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[4] T. Hoshino,et al. Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[5] T. Wajima,et al. Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method , 2017, The Pediatric infectious disease journal.
[6] E. Bancroft,et al. Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007–2014 , 2017, Emerging infectious diseases.
[7] R. Hasan,et al. Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009–2015 , 2016, International journal of mycobacteriology.
[8] T. Wajima,et al. Prevalence of macrolide-non-susceptible isolates among β-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan. , 2016, Journal of global antimicrobial resistance.
[9] H. Hanaki,et al. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[10] Dong‐Gun Lee,et al. Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea. , 2013, Microbial drug resistance.
[11] K. Kimura,et al. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. , 2013, The Journal of antimicrobial chemotherapy.
[12] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[13] A. Hamidi,et al. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries. , 2012, Vaccine.
[14] I. Anthonisen,et al. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[15] H. Sakata,et al. Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[16] S. Yokota,et al. Emergence of Fluoroquinolone-Resistant Haemophilus influenzae Strains among Elderly Patients but Not among Children , 2007, Journal of Clinical Microbiology.
[17] J. Campos,et al. Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability , 2007, Antimicrobial Agents and Chemotherapy.
[18] K. Ubukata,et al. Molecular Evolution of β-Lactam-Resistant Haemophilus influenzae: 9-Year Surveillance of Penicillin-Binding Protein 3 Mutations in Isolates from Japan , 2006, Antimicrobial Agents and Chemotherapy.
[19] D. Rao,et al. DNA mismatch correction in Haemophilus influenzae: characterization of MutL, MutH and their interaction. , 2004, DNA repair.
[20] E. Moxon,et al. Mutations in Haemophilus influenzae Mismatch Repair Genes Increase Mutation Rates of Dinucleotide Repeat Tracts but Not Dinucleotide Repeat-Driven Pilin Phase Variation Rates , 2004, Journal of bacteriology.
[21] T. Popović,et al. Characterization of Encapsulated and Noncapsulated Haemophilus influenzae and Determination of Phylogenetic Relationships by Multilocus Sequence Typing , 2003, Journal of Clinical Microbiology.
[22] K. Yamamoto,et al. Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with β-Lactam Resistance in β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae , 2001, Antimicrobial Agents and Chemotherapy.
[23] R. Singleton,et al. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. , 2000, JAMA.
[24] D. Fish,et al. The Clinical Pharmacokinetics of Levofloxacin , 1997, Clinical pharmacokinetics.
[25] D. Maskell,et al. PCR for capsular typing of Haemophilus influenzae , 1994, Journal of clinical microbiology.
[26] H. Sadoff,et al. Mechanisms of Ampicillin Resistance in Haemophilus influenzae Type B , 1976, Antimicrobial Agents and Chemotherapy.